Medication for the Management of Anxiety Disorders in Children and Adolescents-Reference-Cited by-同舟云学术

Medication for the Management of Anxiety Disorders in Children and Adolescents

Published:2001-03 Issue:3 Volume:30 Page:146-153
ISSN:0090-4481
Container-title:Pediatric Annals
language:en
Short-container-title:Pediatr Ann

Author:

Williams Thomas,Hodgman Christopher

Publisher

SLACK, Inc.

Subject

Pediatrics, Perinatology, and Child Health

Reference13 articles.

1. 1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 4th ed. Washington DC: American Psychiatric Association; 1994:110-113 393-444.

2. 2. Biederman J Rosenbaum JF Chaioff J Kagan J. Behavioral inhibition as a risk factor. In: March JS ed. Anxiety Disorders in Children and Adolescents. New York: Guilford; 1995:61-81.

3. 3. Bernstein GA Shaw K. Practice parameters for the assessment and treatment of children and adolescents with anxiety disorders. / Am Acad Child Adolesc Psychiatry. 1997; 36(suppl 10):69S-84S.

4. 4. Curry JF Murphy LB. Comorbidiry of anxiety disorders. In: March JS ed. Anxiety Disorders in Children and Adolescents. New York: Guilford; 1995:301-320.

5. 5. Stallings P March JS. Assessment. In: March JS ed. Anxiety Disorders in Children and Adolescents. New York: Guilford; 1995:125-150.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective Serotonin Reuptake Inhibitor–Induced Sexual Dysfunction in Adolescents: A Review;Journal of the American Academy of Child & Adolescent Psychiatry;2004-09

2. Pharmacologic management of anxiety disorders in children and adolescents;Current Opinion in Pediatrics;2003-10

3. Generalized Anxiety Disorder;Southern Medical Journal;2003-06

4. Pharmacotherapy of childhood anxiety disorders;Current Psychiatry Reports;2002-08